Cargando…
How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries
We conducted research to assess hospital pharmacists’ familiarity with/interpretation of data requirements for the different regulatory approval frameworks and the impact of this on their approach to substitution in the formulary. The online questionnaire included a small molecule (acetylsalicylic a...
Autores principales: | Sofia, Natalia, Mühlebach, Stefan, Musazzi, Umberto M., Khatib, Rani, Martinez Sesmero, José Manuel, Lipp, Hans-Peter, Surugue, Jacqueline, Di Francesco, Tiziana, Flühmann, Beat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309126/ https://www.ncbi.nlm.nih.gov/pubmed/34371701 http://dx.doi.org/10.3390/pharmaceutics13071010 |
Ejemplares similares
-
Tackling the challenges of nanomedicines: are we ready?
por: Hertig, John B, et al.
Publicado: (2021) -
Medication practice in hospitals: are nanosimilars evaluated and substituted correctly?
por: Knoeff, Josefien, et al.
Publicado: (2018) -
Need for Expansion of Pharmacy Education Globally for the Growing Field of Nanomedicine
por: Barton, Amy E., et al.
Publicado: (2022) -
Considerations on D-mannose Mechanism of Action and Consequent Classification of Marketed Healthcare Products
por: Scaglione, Francesco, et al.
Publicado: (2021) -
Development of Pharmaceutical Nanomedicines: From the Bench to the Market
por: Halwani, Abdulrahman A.
Publicado: (2022)